Cerebrovascular Diseases in Low-income Countries: Challenges and Opportunities

Granieri Katarzyna^*
*Correspondence: Granieri Katarzyna, Department of Neurological Surgery, Pirogov Russian National Research Medical University, Moscow, Russia, Email:

Introduction

Cerebrovascular Diseases (CVDs), including strokes and other conditions affecting blood vessels in the brain, represent a significant public health challenge globally. However, their impact is particularly severe in Low-Income Countries (LICs), where they often lead to high morbidity and mortality rates. Understanding the unique challenges faced by LICs in managing CVDs, as well as the opportunities for improvement, is crucial for devising effective public health strategies and interventions. High prevalence of risk factors LICs frequently face a higher burden of risk factors associated with CVDs. These include hypertension, diabetes and obesity, which are prevalent due to lifestyle factors, limited access to healthcare and inadequate public health education. The lack of preventive measures exacerbates the incidence of cerebrovascular diseases [1]. Limited healthcare infrastructure LICs often grapple with inadequate healthcare facilities and resources. This limitation affects the ability to provide timely and effective treatment for cerebrovascular diseases. Diagnostic tools such as CT scans and MRIs may be scarce and access to specialized neurological care is often limited. Consequently, patients may receive delayed diagnoses and treatments, leading to poorer outcomes, Economic barriers the financial strain on individuals and families affected by CVDs in LICs is considerable. Treatment costs, including hospitalization, medication and rehabilitation, are often prohibitive. Additionally, the loss of productivity due to illness can have severe economic repercussions for families and communities [2].

Description

Lack of public awareness and understanding of cerebrovascular diseases and their risk factors are often low in LICs. This lack of awareness can lead to delays in seeking medical care, as well as insufficient preventive practices and health education. Inadequate research and data research on cerebrovascular diseases in LICs is limited and data on the prevalence, incidence and outcomes of these conditions are often incomplete. This lack of data hinders the development of targeted interventions and policies. Strengthening healthcare systems investing in healthcare infrastructure and increasing access to diagnostic and treatment services can improve outcomes for patients with cerebrovascular diseases. Developing primary healthcare networks that include stroke units and specialized care facilities can make a significant difference [3].

The financial strain on individuals and families affected by CVDs in LICs is considerable. Treatment costs, including hospitalization, medication and rehabilitation, are often prohibitive. Additionally, the loss of productivity due to illness can have severe economic repercussions for families and communities. The economic burden is not only a direct result of medical expenses but also of the long-term care and rehabilitation needs of stroke survivors, which can be extensive and ongoing. Public awareness and understanding of cerebrovascular diseases and their risk factors are often low in LICs. This lack of awareness can lead to delays in seeking medical care, as well as insufficient preventive practices and health education. Without adequate knowledge, individuals may not recognize the symptoms of stroke or understand the importance of managing risk factors, which can lead to more severe health outcomes and increased mortality rates.

Promoting preventive measures enhancing public health campaigns to educate populations about the risk factors for cerebrovascular diseases and the importance of early detection can help reduce incidence rates. Implementing community-based programs to promote healthy lifestyles and regular health check-ups can also be beneficial. Improving access to medications ensuring that essential medications for managing risk factors such as hypertension and diabetes are available and affordable is critical. Partnerships with pharmaceutical companies and international organizations can help address the issue of medication accessibility [4]. Public awareness and understanding of cerebrovascular diseases and their risk factors are often low in LICs. This lack of awareness can lead to delays in seeking medical care, as well as insufficient preventive practices and health education. Without adequate knowledge, individuals may not recognize the symptoms of stroke or understand the importance of managing risk factors, which can lead to more severe health outcomes and increased mortality rates. Fostering International between governments, non-governmental organizations and international health agencies can facilitate the sharing of knowledge, resources and best practices. Support for training healthcare professionals and developing local expertise can strengthen the overall response to cerebrovascular diseases [5].

Addressing cerebrovascular diseases in low-income countries presents a complex array of challenges, from limited healthcare infrastructure to economic barriers and a lack of public awareness. However, there are substantial opportunities for improvement through strategic investments in healthcare systems, preventive measures and research. By focusing on these areas, LICs can improve outcomes for individuals affected by cerebrovascular diseases and reduce the overall burden on their healthcare systems. Effective interventions and policies, supported by international collaboration and community engagement, hold the potential to make a significant impact on the management and prevention of cerebrovascular diseases in low-income settings.

Conclusion

LICs often grapple with inadequate healthcare facilities and resources. This limitation affects the ability to provide timely and effective treatment for cerebrovascular diseases. Diagnostic tools such as CT scans and MRIs may be scarce and access to specialized neurological care is often limited. Consequently, patients may receive delayed diagnoses and treatments, leading to poorer outcomes. Moreover, healthcare systems in these regions may struggle with insufficient training for healthcare professionals, impacting the quality of care provided. LICs frequently face a higher burden of risk factors associated with CVDs. These include hypertension, diabetes and obesity, which are prevalent due to lifestyle factors, limited access to healthcare and inadequate public health education. The lack of preventive measures exacerbates the incidence of cerebrovascular diseases. Additionally, the prevalence of these risk factors is often compounded by economic hardships that limit access to healthy food and regular exercise, further increasing the risk of CVDs.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Wyss-Coray, Tony and Lennart Mucke. “Inflammation in neurodegenerative disease-a double-edged sword.” Neuron 35 (2002): 419-432.

Google Scholar, Crossref, Indexed at

2. Nagyőszi, Péter, Ádám Nyúl‐Tóth, Csilla Fazakas and Imola Wilhelm, et al. “Regulation of NOD‐like receptors and inflammasome activation in cerebral endothelial cells.” J Neurochem 135 (2015): 551-564.

Google Scholar, Crossref, Indexed at

3. Litak, Jakub, Marek Mazurek, Bartłomiej Kulesza and Paweł Szmygin, et al. “Cerebral small vessel disease.” Int J Mol Sci 21 (2020): 9729.

Google Scholar, Crossref, Indexed at

4. Cannistraro, Rocco J., Mohammed Badi, Benjamin H. Eidelman and Dennis W. Dickson, et al. “CNS small vessel disease: A clinical review.” Neurology 92 (2019): 1146-1156.

Google Scholar, Crossref, Indexed at

5. Zotin, Maria Clara Zanon, Lukas Sveikata, Anand Viswanathan and Pinar Yilmaz. “Cerebral small vessel disease and vascular cognitive impairment: From diagnosis to management.” Curr Opin Neurol 34 (2021): 246-257.

Google Scholar, Crossref, Indexed at